Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study

References

• Immunization Action Coalition. 2020 [Accessed 2020 Feb 6th]; https://www.immunize.org/catg.d/p4208.pdf
   Google Scholar
• WHO Influenza (Seasonal). 2020 [Accessed 2021 Feb 15]; https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal)
   Google Scholar
• Centers for Disease Control and Prevention 2020 [Accessed 2021 Feb 15]; https://www.cdc.gov/flu/vaccines-work/vaccineeffect.htm
   Google Scholar
• National Institute of allergy and Infectious Diseases. 2020 [Accessed 2020 Mar 4]; https://www.niaid.nih.gov/diseases-conditions/influenza-diagnosis
   Google Scholar
• CDC Antiviral Drugs. 2020 [Accessed 2021 Feb 15]; https://www.cdc.gov/flu/treatment/whatyoushould.htm
   Google Scholar
• Greenberg DP, Robertson CA, Noss MJ, Blatter MM, Biedenbender R, Decker MD. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults. Vaccine. 2013;31(5):770–76. doi:10.1016/j.vaccine.2012.11.074.
   PubMed Web of Science ®Google Scholar
• Kieninger D, Sheldon E, Lin WY, Yu CJ, Bayas JM, Gabor JJ, Esen M, Fernandez Roure JL, Narejos Perez S, Alvarez Sanchez C, et al. Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged >/=18 years. BMC Infect Dis. 2013;13:343. doi:10.1186/1471-2334-13-343.
   PubMed Web of Science ®Google Scholar
• Van de Witte S, Nauta J, Montomoli E, Weckx J. A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses. Vaccine. 2018;36(40):6030–38. doi:10.1016/j.vaccine.2018.04.043.
   PubMed Web of Science ®Google Scholar
• Jamotte A, Chong CF, Manton A, Macabeo B, Toumi M. Impact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia. BMC Public Health. 2016;16(1):630. doi:10.1186/s12889-016-3297-1.
   PubMed Web of Science ®Google Scholar
• WHO Vaccine Seasons. 2020 [Accessed 2021 Feb 15]; https://www.who.int/ith/vaccines/si_iAh1n1/en/
   Google Scholar
• WHO Influenza. 2020 [Accessed 2021 Feb 15]; https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
   Google Scholar
• Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, et al. Centers for disease control and prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP), 2010. MMWR Recomm Rep. 2010 Aug 6;59(RR–8):1–62. Erratum in: MMWR Recomm Rep. 2010 Aug 13;59(31):993.Erratum in: MMWR Recomm Rep. 2010 Sep 10;59(35):1147.PMID: 20689501.
   PubMedGoogle Scholar
• National Centre for disease Control. 2020 [Accessed 2021 Feb 15]; https://ncdc.gov.in/showfile.php?lid=280
   Google Scholar
• WHO FluNet. 2020 [Accessed 2021 Feb 15]; http://apps.who.int/flumart/Default?ReportNo=12
   Google Scholar
• Chadha MS, Potdar VA, Saha S, Koul PA, Broor S, Dar L, Chawla-Sarkar M, Biswas D, Gunasekaran P, Abraham AM, et al. Dynamics of influenza seasonality at sub-regional levels in India and implications for vaccination timing. PloS One. 2015;10(5):e0124122. doi:10.1371/journal.pone.0124122.
   PubMed Web of Science ®Google Scholar
• Wijnans L, Voordouw B. A review of the changes to the licensing of influenza vaccines in Europe. Influenza Other Respi Viruses. 2016;10(1):2–8. doi:10.1111/irv.12351.
   PubMed Web of Science ®Google Scholar
• Guideline on Influenza Vaccines Non-clinical and Clinical Module. 2016 [Accessed 2020 May 26]; https://www.ema.europa.eu/en/documents/scientific-guideline/influenza-vaccines-non-clinical-clinical-module_en.pdf
   Google Scholar
• Sasaki S, Sullivan M, Narvaez CF, Holmes TH, Furman D, Zheng NY, Nishtala M, Wrammert J, Smith K, James JA, et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest. 2011;121(8):3109–19. doi:10.1172/JCI57834.
   PubMed Web of Science ®Google Scholar
• Sambhara S, McElhaney JE. Immunosenescence and influenza vaccine efficacy. In: Vaccines for Pandemic Influenza. Atlanta (USA): Springer; 2009. p. 413–29.
   Google Scholar
• Reber AJ, Chirkova T, Kim JH, Cao W, Biber R, Shay DK, Sambhara S. Immunosenescence and challenges of vaccination against influenza in the aging population. Aging Dis. 2012;3:68.
   PubMed Web of Science ®Google Scholar
• Haq K, McElhaney JE. Immunosenescence: influenza vaccination and the elderly. Curr Opin Immunol. 2014;29:38–42. doi:10.1016/j.coi.2014.03.008.
   PubMed Web of Science ®Google Scholar
• Dunkle LM, Izikson R, Patriarca PA, Goldenthal KL, Muse D, Cox MMJ. Randomized comparison of immunogenicity and safety of quadrivalent recombinant versus inactivated influenza vaccine in healthy adults 18-49 years of age. J Infect Dis. 2017;216(10):1219–26. doi:10.1093/infdis/jix478.
   PubMed Web of Science ®Google Scholar
• Olafsdottir TA, Alexandersson KF, Sveinbjornsson G, Lapini G, Palladino L, Montomoli E, Del Giudice G, Gudbjartsson DF, Jonsdottir I. Age and influenza-specific pre-vaccination antibodies strongly affect influenza vaccine responses in the Icelandic population whereas disease and medication have small effects. Front Immunol. 2018;8:1872. doi:10.3389/fimmu.2017.01872.
   PubMed Web of Science ®Google Scholar
• Sharma S, Singh VB, Kumar S, Prajapati V, Patel J, Vukkala R, Jangid SK, Sanmukhani J, Gupta G, Patel P, et al. Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults≥ 18 years of age: a randomized, multicenter, phase II/III clinical trial. Hum Vaccin Immunother. 2018;14(6):1362–69. doi:10.1080/21645515.2018.1441654.
   PubMed Web of Science ®Google Scholar
• Beyer WE, McElhaney J, Smith DJ, Monto AS, Nguyen-Van-Tam JS, Osterhaus AD. Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine. 2013;31(50):6030–33. doi:10.1016/j.vaccine.2013.09.063.
   PubMed Web of Science ®Google Scholar
• Castrucci MR. Factors affecting immune responses to the influenza vaccine. Hum Vaccin Immunother. 2018;14(3):637–46. doi:10.1080/21645515.2017.1338547.
   PubMed Web of Science ®Google Scholar
• Pépin S, Donazzolo Y, Jambrecina A, Salamand C, Saville M. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults. Vaccine. 2013;31(47):5572–78. doi:10.1016/j.vaccine.2013.08.069.
   PubMed Web of Science ®Google Scholar
• Noah DL, Hill H, Hines D, White EL, Wolff MC. Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure. Clin Vaccine Immunol. 2009;16(4):558–66. doi:10.1128/CVI.00368-08.
   PubMed Web of Science ®Google Scholar
• Truelove S, Zhu H, Lessler J, Riley S, Read JM, Wang S, Kwok KO, Guan Y, Jiang CQ, Cummings DA. A comparison of hemagglutination inhibition and neutralization assays for characterizing immunity to seasonal influenza A. Influenza Other Respi Viruses. 2016;10(6):518–24. doi:10.1111/irv.12408.
   PubMed Web of Science ®Google Scholar
• Raju Shah SP. Advantages of subunit influenza vaccine: an overall perspective. Indian J Clin Practise. 2018;29(3):253-62.
   Google Scholar
• Beyer W, Palache A, Osterhaus A. Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines. Clin Drug Investig. 1998;15(1):1–12. doi:10.2165/00044011-199815010-00001.
   PubMed Web of Science ®Google Scholar
• Palache AM. Influenza vaccines A reappraisal of their use. Drugs. 1997;54:841–56.
   PubMed Web of Science ®Google Scholar
• Wood JM, Williams MS. History of inactivated influenza vaccines. In: Nicholson KG, Webster RG, Hay AJ, editors. Textbook of influenza. London (UK):: Blackwell Science; 1998. p. 317–23.
   Google Scholar